Abstract

Consumption of polyphenol‐rich grapes has previously shown cardioprotective effects. This randomized, double‐blind, crossover study aimed to determine the impact of whole grapes on biomarkers of cardiovascular disease risk compared to placebo. We examined plasma lipids, glucose, insulin, and C‐reactive protein in obese adults (mean BMI 39.2 ± 11.7) in good health. Diets included 60 g of whole grape powder (WGP), equivalent to 2 cups whole grapes providing 300 mg total polyphenols, or placebo(C) matched in calories and appearance providing 0 mg polyphenols. Subjects completed two 4‐wk intervention periods, separated by a 2‐wk washout, during which they consumed WGP or C once daily in addition to low polyphenol diets. Fasting blood samples were drawn at beginning and end of each intervention period. Acute postprandial effects at 1, 3, and 5 h were examined following consumption of WGP or C with a standardized high fat, high carbohydrate test meal. Preliminary data reveals subjects receiving WGP had no significant differences in fasting metabolic parameters compared to C, with exception of HDL (p<0.05). Similarly, postprandial AUC for glucose, insulin, and TG did not differ. Further evaluation is needed to determine if grape consumption improves other metabolic biomarkers in the obese population.Grant Funding Source: Supported by CTGC and USDA CRIS CA‐S*‐NTR‐6316‐H

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.